Analytical Testing Lab Supplier Profiles from Pixis Labs and SPEX CertiPrep.
COMPANY DESCRIPTION
Pixis Labs sets the standard for quality analytics in the CBD and hemp markets nationwide and raises the bar for Oregon cannabis laboratories. In partnership with Columbia Food Labs, and as a member of Tentamus Group, Pixis Labs boasts top-of-the-line instrumentation and nearly 40 years of analytical expertise. With low detection limits and robust methodologies, Pixis Labs is ahead of the curve for changing requirements and emerging markets, offering services beyond compliance. We pride ourselves on building a community of sustainable business partnerships through detailed analyses and accurate reporting. Contact us for a custom service and price quote.
CHIEF SERVICES SUPPORTED
Pixis Labs offers you reliable data and turnaround times with transparent, professional communication and competitive pricing.
MAJOR PRODUCTS
Pixis Labs offers accurate and clear reporting, catered to your market and industry.
Consultation services are available upon request.
STATES SERVED
Pixis Labs’ services are available nationally for hemp and CBD analyses, as well as nutritional, environmental, and microbiological testing. We are proud to serve the Oregon cannabis market for compliance and R&D testing.
Pixis Labs
12423 NE Whitaker Way, Portland, OR 97230 USA
TELEPHONE
(503) 254 1794
EMAIL
customerservice@pixislabs.com
KEY PERSONNEL
Derrick Tanner, General Manager
Jen Stiles, Operations Manager
Kelly O’Connor, Sales Rep
COMPANY DESCRIPTION
SPEX CertiPrep has been servicing the scientific community since 1954. We are a leading manufacturer of certified reference materials (CRMs) and calibration standards for analytical spectroscopy and chromatography. We offer a full range of inorganic and organic CRMs. We are certified by DQS to ISO 9001:2015 and are proud to be accredited by A2LA to ISO/IEC 17025:2005 and ISO 17034:2016. The scope of our accreditation is the most comprehensive in the industry and encompasses all our manufactured products.
MAJOR PRODUCTS
We offer analytical standards for medicinal and recreational cannabis testing. SPEX CertiPrep offers ISO 17034 CRMs for all of the common contaminants such as pesticide residues, residual solvents, and heavy metals as well as qualitative analysis CRMs such as terpenes and cannabinoids. As the industry demands change and regulations are put into place, we continually update our product offerings.
STATES SERVED
Nationwide for the US and Canada.
SPEX CertiPrep
203 Norcross Avenue, Metuchen, NJ 08840 USA
TELEPHONE
Toll free: (800) 522-7739
(732) 549-7144
Fax: (732) 494-1747
EMAIL
crmsales@spex.com
LOCATIONS OF OTHER OFFICES AND FACILITIES
Stanmore, UK
+44 (0) 208 204 6656
KEY PERSONNEL
Christy Greene, Territory Manager
Jeff Akers, Territory Manager
Rebekah Biermann, Territory Manager
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.